dendreon corp (DNDN:NASDAQ GS)
John H. Johnson
Executive Chairman, Chief Executive Officer and President, Dendreon Corp.
|Age||Total Calculated Compensation||This person is connected to 26 board members in 2 different organizations across 9 different industries.|
See Board Relationships
As of Fiscal Year 2012
Mr. John H. Johnson has been the Chief Executive Officer and President at Dendreon Corp. since February 2012. Mr. Johnson is the Founder of The Atlantic Foundation. Mr. Johnson served as the Chief Executive Officer of Savient Pharmaceuticals, Inc. from January 31, 2011 to February 1, 2012 and served as its President until February 1, 2012. He served as the President and Head of Lilly Oncology (Oncology Business Unit) and Senior Vice President of Eli Lilly and Company ...
1301 2nd AvenuePhone: 206-256-4545
Seattle, Washington 98101
Board Members Memberships*
Former Chief Executive Officer, President and Director
Former Chairman of the Board
Former President of Global Oncology Business Unit - Eli Lilly and Company
Director, Member of Nominating & Governance Committee and Member of Audit Committee
Chairman, Member of Audit Committee and Member of Nominating & Corporate Governance Committee
Executive Chairman, Chief Executive Officer and President
East Stroudsburg University
|Richard F. Pops||Chairman of the Board and Chief Executive Officer|
|Jean-Jacques Bienaimé||Chief Executive Officer and Director|
BioMarin Pharmaceutical Inc.
|James A. Bianco M.D.||Principal Founder, Chief Executive Officer, President and Executive Director|
Cell Therapeutics, Inc.
|Rajesh C. Shrotriya M.D.||Chairman, Chief Executive Officer, President, Chairman of Placement Committee and Chairman of Product Acquisition Committee|
Spectrum Pharmaceuticals, Inc.
|Bruce C. Cozadd||Co-Founder, Executive Chairman and Chief Executive Officer|
Jazz Pharmaceuticals Public Limited Company
|$722.2K||Compensation as of Fiscal Year 2013.|